pembrolizumab
merck
['kn716', 'melanoma']
improving distant metastasis free survival &amp; updated relapse-free survival for anti-pd1 in stage iib/c #melanoma from kn716 - just in time for #smr22! hope all are enjoying edinburgh! 
Immunotherapy of Cancer • Melanoma • Phase I Clinical Trials • Targeted Therapies for Cancer • Lab: @ImmunoTiil • Disclosures at https://t.co/mcWOaTaiZn…